top of page

News
Xolair Now Available in Pharmacies: A Breakthrough for Patients with Chronic Spontaneous Urticaria (CSU) in Lombardy
Starting August 4, 2025 , a new simplified process for prescribing and dispensing the biological drug omalizumab (Xolair) , used in the...
Aug 6, 20251 min read


Take part in the Chronic Spontaneous Urticaria (CSU) Survey: Your Experience Can Make a Difference
If you are living with Chronic Spontaneous Urticaria (CSU) or care for someone affected by it, your experience is valuable . The ARCO...
Apr 24, 20252 min read


Shared Decision-Making Tool for Chronic Urticaria
Chronic Urticaria is a condition that affects approximately 1% of the global population, with a prevalence twice as high in women...
Mar 18, 20251 min read


2024 Budget of ARCO - Best wishes from Elena Radaelli.
Dear members, This year has been full of new developments and important goals achieved for our association and for the care of urticaria....
Jan 2, 20251 min read


bottom of page
